Historial de carrera de Rita Laeufle
Antiguos cargos conocidos de Rita Laeufle.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
IMUGENE LIMITED | Director Técnico/Científico/I+D | 30/09/2020 | 31/01/2022 |
SFJ Pharmaceuticals, Inc.
SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology SFJ Pharmaceuticals, Inc. develops pharmaceuticals drugs. It offers drugs for cancer, kidney, thyroid, leukemia, and lung cancer. The company was founded by Roberto DeBenedetto in January 2009 and is headquartered in Pleasanton, CA. | Director Técnico/Científico/I+D | 01/04/2017 | 01/02/2019 |
COHERUS BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 01/03/2016 | 01/09/2017 |
CLOVIS ONCOLOGY, INC. | Director Técnico/Científico/I+D | 01/05/2015 | 01/01/2016 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Director Técnico/Científico/I+D | 01/03/2013 | 01/04/2015 |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/01/2009 | 01/02/2013 |
Hoffman-La Roche, Inc. | Corporate Officer/Principal | - | - |
Takeda Canada, Inc.
Takeda Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda Canada, Inc. is a biopharmaceutical company based in Mississauga, CA. Takeda provides financial data for investors and is focused on developing innovative medicines to make a difference in people's lives. The Canadian company is committed to discovering and delivering life-transforming treatments in the areas of oncology, rare genetics and hematology, neuroscience, and gastroenterology. Takeda also invests in plasma-derived therapies and vaccines. The company's employees are dedicated to improving the quality of life for patients and working with healthcare partners in approximately 80 countries and regions. | Director Técnico/Científico/I+D | - | - |
ONCOLYTICS BIOTECH INC. | Director Técnico/Científico/I+D | 29/11/2018 | - |
Formación de Rita Laeufle.
University of Freiburg | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Canadá | 3 |
Australia | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 7 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 9 |
Consumer Services | 2 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
ONCOLYTICS BIOTECH INC. | Health Technology |
IMUGENE LIMITED | Health Technology |
COHERUS BIOSCIENCES, INC. | Health Technology |
Empresas privadas | 6 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Clovis Oncology, Inc.
Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of innovative anti-cancer agents in the United States, Europe, and additional international markets. Its U.S. marketed product, Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is approved for use in the maintenance treatment and treatment of eligible adult patients with recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer, and also for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC), which have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy. In Europe, Rubraca is approved for use in recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. The company was founded by Andrew R. Allen, Gillian C. Ivers-Read, Patrick J. Mahaffy, and Erle T. Mast on April 20, 2009 and is headquartered in Boulder, CO. | Health Technology |
SFJ Pharmaceuticals, Inc.
SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology SFJ Pharmaceuticals, Inc. develops pharmaceuticals drugs. It offers drugs for cancer, kidney, thyroid, leukemia, and lung cancer. The company was founded by Roberto DeBenedetto in January 2009 and is headquartered in Pleasanton, CA. | Health Technology |
Takeda Canada, Inc.
Takeda Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda Canada, Inc. is a biopharmaceutical company based in Mississauga, CA. Takeda provides financial data for investors and is focused on developing innovative medicines to make a difference in people's lives. The Canadian company is committed to discovering and delivering life-transforming treatments in the areas of oncology, rare genetics and hematology, neuroscience, and gastroenterology. Takeda also invests in plasma-derived therapies and vaccines. The company's employees are dedicated to improving the quality of life for patients and working with healthcare partners in approximately 80 countries and regions. | Health Technology |
Hoffman-La Roche, Inc. | Health Technology |
- Bolsa de valores
- Insiders
- Rita Laeufle
- Experiencia